The protein hydrolysis enzymes market is expected to reach USD 2.9 billion by 2027, growing at a CAGR of 6.2% from 2022 to 2027, according to a new report by MarketsandMarkets™.
The various functions of protein hydrolysis enzymes in food, detergent, food, pharmaceutical, and textile and leather applications are driving the growth of the market. In the food industry, there is an increasing development for use in new food products which is expected to drive the consumption of protein hydrolysis enzymes in the coming years. In baking, protein hydrolysis enzymes are used for the purpose of weakening gluten to provide plastic properties, thin dough rolling and retaining decorative impressions of baked goods. In the meat industry, protein hydrolysis enzymes are mainly used for meat tenderization, as their functional properties are perfectly suited for marinating meat products and improving the flavor of meat, preventing loss of cooking and for other purposes. In recent years, protein hydrolysis enzymes are also popular because protein hydrolysis enzymes break down protein into peptides and amino acids, which helps to increase the precipitation process in beverages and also helps to increase the aromatic substances present in the drink. With the growing demand from the food industry, market players are involved in research and development and the launch of new products to meet the growing market demand. In November 2021, Novozymes expanded its protein ingredient product portfolio by launching a new protease enzyme named Formea Prime. This product was launched with the aim of helping beverage formulators overcome the typical challenges of using whey protein hydrolysates.
Download the PDF brochure:
Protein hydrolysis is also widely used in the detergent industry. They represent one of the main groups of enzymes and are characterized by their widespread use in detergents. In addition to increasing the level of cleaning, proteins also provide environmental benefits by reducing energy consumption through shorter wash times, lower wash temperatures and reduced water consumption.
Global meat production and consumption has grown rapidly over the past decades. According to the OECD-FAO Agricultural Outlook, global meat supply is expected to reach 374 Mt by 2030. Growth in global consumption demand for meat protein over the next decade is expected to increase by 14% by 2030.
For these reasons, new food enzymes, especially protein hydrolysis, are rapidly being adopted by the meat industry as they are used in the animal feed industry for animal nutrition purposes; essential to meet the growing demand for meat. It has also facilitated the development of important new technologies to advance their use and availability. The importance of the feature is expected to be maintained for a long time due to the lack of effective substitutes for protein hydrolysis enzymes.
Pharmaceuticals segment is identified as the fastest growing segment among the various applications of protein hydrolysis enzymes during the forecast period
Protein hydrolysis enzymes are widely used for the preparation of drugs, such as ointments for wound debridement and used in denture cleansers. Protein hydrolysis enzymes from microbial sources are preferred over those from plant and animal sources due to their high biochemical diversity and genetic susceptibility. Application of microbial protein hydrolysis enzymes in pharmaceutical industry such as serrapeptase, serrazim, lysostaphin, L-asparaginase, L-glutaminase, streptokinase, streptokinase-streptodornase and xiaflex. These enzymes are used to treat cancer, cardiovascular disease, respiratory tract disorders and inflammation. The application of plant protein hydrolysis enzymes in the pharmaceutical industry includes papain and bromelain. Papain is an effective enzyme used in the treatment of dyspepsia and other digestive disorders. Papain is used to treat ringworm, remove warts, and heal skin lesions due to its ability to break down dead tissue without harming living tissue. Bromelain is used in the treatment of cardiovascular diseases, the scaling of burns and as an anti-inflammatory agent. Animal protein hydrolysis enzymes are applied in the pharmaceutical industry, including pepsin, trypsin and chymotrypsin, hyaluronidase, urokinase and collagenase. Pepsin is mainly used to aid in the digestion of proteins. Trypsin can be used as a wet or dry dressing as well as an ointment. Hyaluronidase aids in drug delivery when combined with other drugs such as antibiotics, adrenaline, heparin, and local anesthesia. Urokinase and collagenase in the removal of blood clots and skin ulcers.
Conduct an investigation: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=12636477
In the Protein Hydrolysis Enzyme Market, “Microbial” Segment Records the Highest Growth Over the Forecast Period
The microbial segment is the fastest growing segment as microorganisms are an excellent source of enzymes due to their high biochemical diversity and susceptibility to genetic manipulation. In addition, protein hydrolysis enzymes from microorganisms are preferred because they possess the desired characteristics for their applications in baking, brewing, detergents, fermented products, pharmaceuticals, textiles, and food processing. leather, among others. The growing need for sustainable solutions is driving the demand for microbial enzymes. Microbes have been and still are one of the most important and beneficial sources of many enzymes. Major markets for these enzymes include North America and Europe. Additionally, the demand for microbial enzymes in the Asia-Pacific region is also expected to grow rapidly, especially in China, Japan, and India due to the growing industrialization in the region. Microbial manufacturing companies include Novozymes (Denmark), Advanced Enzymes Technologies (India), Aumgene Biosciences (India), Amano Enzyme (India).
Asia-Pacific region is expected to witness the highest growth rate of protein hydrolysis enzymes market over the forecast period.
In the Asia-Pacific region, the protein hydrolysis enzymes market is largely driven by the increasing use in detergents, pharmaceuticals and food industries. Countries in the region such as China, India, Japan and South Korea are highly regarded in the global pharmaceutical market for their continuous technological innovation. According to the National Bureau of Statistics (NBS), China ranks second in the world in terms of research and development. Moreover, investment in research and development is expected to increase by 7% annually from 2021 to 2025. According to the April 2022 report of India Pharmaceutical Industry Analysis, the Indian pharmaceutical market has been growing by 13.9% of its overall revenue in January 2022. Increase in technological innovations in the pharmaceutical segment coupled with growing investments in research and development are expected to propel the market growth in the region.
The major players in this market are Novozymes (Denmark), Associated British Foods (UK), DSM (Netherlands), DuPont (US), BASF (Germany), Advanced Enzymes Technologies (India) and Chr. Hansen (Denmark).
food enzymes market by type (carbohydrases, proteases, lipases, polymerases and nucleases), source, application (food and beverages), formulation and region (North America, Europe, Asia Pacificand South America) – Global Forecast to 2026
Enzyme Market by Product Type (Industrial Enzymes & Specialty Enzymes), Source (Microorganism, Plant & Animal), Type, Industrial Enzymes Application, Specialty Enzymes Application & Region – Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Email: [email protected]